Shares of Sun Pharmaceuticals, India’s largest drug manufacturer, gained more than 50% over the last one year. In its latest results, the company also posted a 34% on year jump in Q4 profit. While the stock did decline slightly this week, pharma analysts are positive on the stock as the company has shown growth across key therapies. The biggest reason for optimism is Sun Pharma’s global specialty business, which exceeded USD1 billion in sales in
How a 2012 bet supercharged Sun Pharma
